Article
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies
26 Apr 2024
Abstract excerpt
Alternative splicing (AS) is an important molecular biological mechanism regulated by complex mechanisms involving a plethora of cis and trans-acting elements. Furthermore, AS is tissue specific and altered in various pathologies, including infectious, inflammatory, and neoplastic diseases. Recently developed immuno-oncological therapies include monoclonal antibodies (mAbs) and chimeric antigen receptor (CAR) T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
